Guide for Authors
Aims and scope
Formerly Archives des Maladies du Cœur et des Vaisseaux.
Archives of Cardiovascular Diseases is a monthly publication of the French Society of Cardiology, edited by Elsevier.
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.
Archives of Cardiovascular Diseases (formerly Archives des maladies du coeur et des vaisseaux) aims to publish the highest quality material, both clinical and scientific, on all aspects of cardiovascular medicine. It includes articles related to research findings, editorials and reviews. It provides a forum for the exchange of information on all aspects of cardiovascular medicine, including educational issues. Archives of Cardiovascular Diseases is an international, English-language, peer-reviewed journal concerned with cardiovascular medicine. It is an official journal of the Société francaise de cardiologie and is published monthly. Before proceeding to the online submission site, please prepare your manuscript according to the instructions listed below under the appropriate heading. All manuscripts correctly submitted to the Archives of Cardiovascular Diseases will first be reviewed by the editors. All papers considered suitable by the editors to progress further in the review process will undergo appropriate peer review, and papers provisionally accepted for publication will undergo a detailed statistical review if necessary. Manuscripts must be submitted with a cover letter stating that: (1) the paper is not under consideration elsewhere; (2) none of the paper’s contents have previously been published; (3) all the authors have read and approved the manuscript and (4) giving full disclosure of any potential conflict of interest (see conflict of interest policy).
Types of articles The journal accepts Clinical research papers (original articles), Reviews, Guidelines, Editorials and Letters to the editor.
Original articles
Manuscript form: The manuscript does not exceed 5000 words, counting the title page and all other pages except tables.
Maximum number of references 50
Maximum number of figures 8
The order of the sections is as follows: (1) Title page; (2) Structured abstract in English and French, with keywords and mots-cles; (3) List of abbreviations; (4) Body of the text; (5) References; (6) Figure legends; (7) Tables and (8) Figures.
Reviews
The editors will consider both invited and uninvited review articles. Such manuscripts must adhere to the aforementioned length guidelines (5000 words maximum) and require an unstructured abstract (250 words).
Review in translational cardiovascular medicine
Review a contemporary topic of translational science. Authors may be invited by the editorial committee or send by e-mail their unsolicited proposal to the office before submitting their paper. Manuscripts may be written by a single author or an author group. Unstructured abstract of no more than 250 words. Should not exceed 5,000 words; the number of references should not exceed 50. Authors are asked to provide a central illustration (line or pictorial) that summarizes an important message of the review. Maximum number of figures/tables/illustrations : 5.
Editorial comments
Where appropriate, the editors (and reviewers) may suggest an editorial comment to put a paper or a result into perspective (1500 words maximum, 15 references).
Letters to the Editor
Do not exceed 500 words and focus on a specific article that has appeared in Archives of Cardiovascular Diseases. Letters must be submitted within one month of the print issue date of the article. No original data may be included. Include the cited article as a reference.
Research letters
Short, original research letters will also be considered for publication in a special section of Archives of Cardiovascular Diseases. These focused letters should not exceed 1000 words and 8 references, with 1 figure or table. Research letters should not include any abstract or subheadings. Online supplemental materials for methods and results are permitted. Research letters will be peer reviewed in a manner identical to original research articles.
Contact details All manuscripts must be submitted electronically http://www.editorialmanager.com/acvd/default.aspx
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
Ethics in publishing
Please see our information on Ethics in publishing.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Contributors
Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure.
Authorship All authors should validate the submission letter and state that they have read and approved the paper. Authorship in general has been discussed in the following references (http://bmj.com/cgi/collection/authorship) and (http://authors.nejm.org/Misc/Policies.asp).
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submission Please submit your article via https://www.editorialmanager.com/ACVD/default.aspx.
Referees
Please submit the names and institutional e-mail addresses of several potential referees. For more details, visit our Support site. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
Peer review
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups. More information on types of peer review.
Double anonymized review
This journal uses double anonymized review, which means the identities of the authors are concealed from the reviewers, and vice versa. More information is available on our website. To facilitate this, please include the following separately:
Title page (with author details): This should include the title, authors' names, affiliations, acknowledgements and any Declaration of Interest statement, and a complete address for the corresponding author including an e-mail address.
Anonymized manuscript (no author details): The main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors' names or affiliations.
……
更多详情：
https://www.elsevier.com/journals/archives-of-cardiovascular-diseases/1875-2136/guide-for-authors
